ACTB and chronic kidney disease: Compared to healthy controls, patients with CKD 1–5 showed a 3-4-fold increase in the NQO1 gene expression (3.1 for NQO1/ACTB, 3.5 for NQO1/RPL41, and 4.2 for NQO1/TBP).